International Society for the Study of Women's Sexual Health

NEWS

FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -

Save the Date


ISSWSH Fall Course 2017

  November 2-4, 2017  13 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...


ISSWSH Annual Meeting 2018

  February 8-11, 2018  111 days left
  Hilton San Diego on Mission Bay
San Diego, CA, USA

Read more...

Latest Tweets

Learn state of the art info on sexual health in pregnancy and the post-partum ISSWSH Fall Course, Nov 2-4, Scottsdale #ISSWSH2017 ISSWSH
Opinion: On the relevance of maintaining subjective #arousal disorder in the diagnostic nomenclature https://t.co/vJ6EERT31P ISSWSH
Learn about the relationship between #sexual and #cardiovascular #health in women: DOI: https://t.co/eRjbjrr0Ym ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville MN, 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.